At this time, how are you using MRD testing for clinical management of patients with multiple myeloma?

Off a clinical protocol, I only routinely use MRD (clonoSEQ) in a very specific setting.

That setting is low risk patients who have received autologous transplant as part of first line therapy and did well. Specifically, if the patient's response to first line therapy is VGPR or better at day+60, th...